TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (3y) (2013 - 2026)
TherapeuticsMD (TXMD) Interest Coverage Ratio Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -3.69% |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 75.30% |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -72.71% |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -2.64% |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 37.62% |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | TherapeuticsMD | 23.54 Mn | 14.35 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 27.73% |
| Mar 31, 2026 | 55.76% |
| Dec 31, 2025 | -103.34% |
| Sep 30, 2025 | 49.56% |
| Jun 30, 2025 | -12.53% |
| Mar 31, 2025 | -60.47% |
| Dec 31, 2024 | -267.60% |
| Sep 30, 2024 | 53.78% |
| Jun 30, 2024 | -16.18% |
| Mar 31, 2024 | 46.70% |
| Dec 31, 2023 | -80.56% |
| Sep 30, 2023 | -7.57% |
| Jun 30, 2023 | 4.15% |
| Mar 31, 2023 | 9.19% |
| Dec 31, 2022 | 204.51% |
| Sep 30, 2022 | -117.85% |
| Jun 30, 2022 | 46.30% |
| Mar 31, 2022 | 64.62% |
| Dec 31, 2021 | 71.76% |
| Sep 30, 2021 | -119.77% |